Human Reproduction, Vol. 14, No. 1, 183-185,
January 1999
© 1999 European Society of Human Reproduction and Embryology
The effect of pituitary desensitization on ovarian volume measurements prior to in-vitro fertilization
1 Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine and 2 University of Maryland School of Medicine, Baltimore, USA
The measurement of ovarian volume has been recently shown to predict follicular response in in-vitro fertilization (IVF), specifically a lower number of retrieved oocytes with decreasing ovarian volume. This test appears to be better than basal follicle-stimulating hormone (FSH) as a prognostic measure of ovarian reserve. However, the effect of pituitary desensitization on ovarian volume has not been previously investigated. We prospectively evaluated 38 women undergoing IVF using a long luteal leuprolide acetate (LA) protocol. All women had their ovarian volume measurements performed on day 21, the day of LA start, and again on the day of gonadotrophin start. The mean age was 30.6 ± 3.9 years (range 2337). Basal FSH was 5.4 ± 1.9 IU/l (range 1.210.2). The mean preLA ovarian volume was 7.0 ± 3.6 cm3 (left ovary 6.8 ± 3.9, right ovary 7.1 ± 3.8), compared to 6.3 ± 4.2 cm3 postLA (left ovary 6.0 ± 4.9, right ovary 6.5 ± 4.8) (not significant). The mean number of small antral follicles noted in both ovaries was also unchanged after pituitary desensitization. Pituitary desensitization using LA had no effect on overall ovarian volume measurements. The total number of retrieved oocytes decreased with increasing age and decreasing ovarian volume.
Key words: IVF/leuprolide acetate/ovarian volume/ultrasound
3 To whom correspondence should be addressed at: 405 W. Redwood St, Baltimore, MD 21201, USA
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Jayaprakasan, J.F. Hopkisson, B.K. Campbell, J. Clewes, I.R. Johnson, and N.J. Raine-Fenning Quantification of the effect of pituitary down-regulation on 3D ultrasound predictors of ovarian response Hum. Reprod., July 1, 2008; 23(7): 1538 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Balasch, F. Fabregues, J. Penarrubia, F. Carmona, R. Casamitjana, M. Creus, D. Manau, G. Casals, and J. A. Vanrell Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH Hum. Reprod., July 1, 2006; 21(7): 1884 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Y. Ng, C. C. W. Chan, O. S. Tang, and P. C. Ho Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment Hum. Reprod., June 1, 2005; 20(6): 1647 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.C.W. Chan, E.H.Y. Ng, C.F. Li, and P.C. Ho Impaired ovarian blood flow and reduced antral follicle count following laparoscopic salpingectomy for ectopic pregnancy Hum. Reprod., October 1, 2003; 18(10): 2175 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dada, O. Salha, V. Allgar, and V. Sharma Utero-ovarian blood flow characteristics of pituitary desensitization Hum. Reprod., August 1, 2001; 16(8): 1663 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. I. Sharara and H. D. McClamrock Use of microdose GnRH agonist protocol in women with low ovarian volumes undergoing IVF Hum. Reprod., March 1, 2001; 16(3): 500 - 503. [Abstract] [Full Text] [PDF] |
||||
